scholarly journals The Role of "Early Palliative Care" in Treatments of Advanced Lung Cancer

Haigan ◽  
2020 ◽  
Vol 60 (7) ◽  
pp. 936-941
Author(s):  
Akira Inoue
CHEST Journal ◽  
2020 ◽  
Vol 158 (6) ◽  
pp. 2266-2267
Author(s):  
Sai-Ching Jim Yeung ◽  
Ahmed Elsayem

Lung Cancer ◽  
2015 ◽  
Vol 90 (2) ◽  
pp. 135-138 ◽  
Author(s):  
A. Janssens ◽  
L. Teugels ◽  
S. Kohl ◽  
T. Michielsen ◽  
J.P. van Meerbeeck

2013 ◽  
Vol 173 (4) ◽  
pp. 283 ◽  
Author(s):  
Jaclyn Yoong ◽  
Elyse R. Park ◽  
Joseph A. Greer ◽  
Vicki A. Jackson ◽  
Emily R. Gallagher ◽  
...  

2018 ◽  
Vol 32 (4) ◽  
pp. 757-766 ◽  
Author(s):  
Ryan D Nipp ◽  
Areej El-Jawahri ◽  
Lara Traeger ◽  
Jamie M Jacobs ◽  
Emily R Gallagher ◽  
...  

Background: Early palliative care interventions enhance patient outcomes, including quality of life, mood, and coping, but it remains unclear whether certain subgroups of patients are more likely to benefit from early palliative care. We explored whether age and sex moderate the improved outcomes seen with early palliative care. Methods: We performed a secondary analysis of data from a randomized trial of 350 patients with advanced lung and non-colorectal gastrointestinal cancer. Patients received an early palliative care intervention integrated with oncology care or usual oncology care alone. We used linear regression to determine if age (older or younger than 65) and sex moderated the effects of the intervention on quality of life (Functional Assessment of Cancer Therapy–General (FACT-G)), depression symptoms (Patient Health Questionnaire 9 (PHQ-9)), and coping (Brief COPE) within lung and gastrointestinal subgroups. Results: At 24 weeks, younger patients with lung cancer receiving early palliative care reported increased use of active coping ( B = 1.74; p = 0.02) and decreased use of avoidant coping ( B = –0.97; p = 0.02), but the effects of early palliative care on these outcomes were not significant for older patients. Male patients with lung cancer assigned to early palliative care reported better quality of life (FACT-G: B = 9.31; p = 0.01) and lower depression scores (PHQ-9: B = –2.82; p = 0.02), but the effects of early palliative care on these outcomes were not significant for female patients. At 24 weeks, we found no age or sex moderation effects within the gastrointestinal cancer subgroup. Conclusion: Age and sex moderate the effects of early palliative care for patients with advanced lung cancer. Early palliative care may need to be tailored to individuals’ unique sociodemographic and clinical characteristics.


2016 ◽  
Vol 47 (3) ◽  
pp. 1010-1012 ◽  
Author(s):  
Annelies Janssens ◽  
Liesbeth Teugels ◽  
Sisca Kohl ◽  
Toke Michielsen ◽  
Bert Leysen ◽  
...  

2021 ◽  
Vol 27 (4) ◽  
pp. 205-212
Author(s):  
Jenny Osborne ◽  
Helen Kerr

Background: Rapid identification of the palliative care needs of individuals with a diagnosis of advanced lung cancer is crucial to maximise the patient's quality of life by upholding exemplary standards of patient-centred holistic care. The clinical nurse specialist is in an ideal position to contribute to the identification and management of the palliative care needs of individuals with advanced lung cancer through the assessment and timely prescribing of medications to manage distressing symptoms. Aim: This paper reviews and critiques the role of the clinical nurse specialist as an independent non-medical prescriber in the management of palliative symptoms in end-of-life care for patients with advanced lung cancer. Results: Published literature highlights the positive impact the clinical nurse specialist has as a non-medical prescriber in addressing the palliative needs of individuals with lung cancer. However, there are barriers and challenges, and to overcome these, maximising resources and the availability of support is required to ensure the delivery of timely, person-centred care. Conclusion: The clinical nurse specialist as a non-medical prescriber is an evolving role. There are a range of factors that may influence the clinical nurse specialist to confidently and competently undertake this role. These include the perception that there will be an escalation in the workload, concerns about increased accountability and inadequate mentoring for this new role. To incentivise this role, multidisciplinary support is essential in promoting the clinical nurse specialist's confidence for developing this service to individuals with advanced lung cancer.


2020 ◽  
Vol 9 (4) ◽  
pp. LMT39
Author(s):  
Irena Tan ◽  
Kavitha Ramchandran

Palliative care (PC) is the care of patients and their families with serious illness and is rapidly becoming an important part of the care of cancer patients. Patients with advanced lung cancer are a highly symptomatic population of patients and clearly experience benefits in quality of life and potentially benefits in overall survival when PC is incorporated early on after diagnosis. However, referrals to PC are still reliant on clinical judgment of patient prognosis and symptom burden. Moving forward, improving the integration of PC and lung cancer care will require more efficient real-time screening of patient symptoms, which may be accomplished through the use of patient-reported outcomes.


Sign in / Sign up

Export Citation Format

Share Document